Infection — Glove-based Care in the NICU to Prevent Late Onset Sepsis
Citation(s)
Alemagno SA, Guten SM, Warthman S, Young E, Mackay DS Online learning to improve hand hygiene knowledge and compliance among health care workers. J Contin Educ Nurs. 2010 Oct;41(10):463-71. doi: 10.3928/00220124-20100610-06. Epub 2010 Jun 8.
Coffin SE Fighting infections in the neonatal intensive care unit: gloves on or off? JAMA Pediatr. 2014 Oct;168(10):885-7. doi: 10.1001/jamapediatrics.2014.1269.
Jefferies JM, Cooper T, Yam T, Clarke SC Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit--a systematic review of risk factors and environmental sources. J Med Microbiol. 2012 Aug;61(Pt 8):1052-61. doi: 10.1099/jmm.0.044818-0. Epub 2012 Jun 8. Review.
Kaufman DA, Blackman A, Conaway MR, Sinkin RA Nonsterile glove use in addition to hand hygiene to prevent late-onset infection in preterm infants: randomized clinical trial. JAMA Pediatr. 2014 Oct;168(10):909-16. doi: 10.1001/jamapediatrics.2014.953.
Klein BS, Perloff WH, Maki DG Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med. 1989 Jun 29;320(26):1714-21.
Samuelsson A, Isaksson B, Hanberger H, Olhager E Late-onset neonatal sepsis, risk factors and interventions: an analysis of recurrent outbreaks of Serratia marcescens, 2006-2011. J Hosp Infect. 2014 Jan;86(1):57-63. doi: 10.1016/j.jhin.2013.09.017. Epub 2013 Oct 23.
Sharma VS, Dutta S, Taneja N, Narang A Comparing hand hygiene measures in a neonatal ICU: a randomized crossover trial. Indian Pediatr. 2013 Oct;50(10):917-21. Epub 2013 Mar 5.
Tan SG, Lim SH, Malathi I Does routine gowning reduce nosocomial infection and mortality rates in a neonatal nursery? A Singapore experience. Int J Nurs Pract. 1995 Nov;1(1):52-8. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.